These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3086202)

  • 1. Potentiating effect of glibenclamide on the occurrence of alloxan diabetes in rats.
    Katsumata K; Katsumata Y
    Horm Metab Res; 1986 Apr; 18(4):277-8. PubMed ID: 3086202
    [No Abstract]   [Full Text] [Related]  

  • 2. The potentiating effect of the simultaneous administration of tolbutamide, glibenclamide, and gliclazide on the development of alloxan-induced diabetes in rats.
    Katsumata K; Katsumata Y
    Horm Metab Res; 1990 Jan; 22(1):51-2. PubMed ID: 2106472
    [No Abstract]   [Full Text] [Related]  

  • 3. Potentiating effects of combined usage of three sulfonylurea drugs on the occurrence of alloxan diabetes in rats.
    Katsumata K; Katsumata Y; Ozawa T; Katsumata K
    Horm Metab Res; 1993 Feb; 25(2):125-6. PubMed ID: 8458609
    [No Abstract]   [Full Text] [Related]  

  • 4. Potentiating effect of glibenclamide on the occurrence of streptozotocin diabetes.
    Ikeda T; Takeuchi T; Ito Y; Murakami I; Mokuda O; Tominaga M; Mashiba H
    Horm Metab Res; 1986 May; 18(5):352. PubMed ID: 2941353
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of a single administration of tolbutamide on the occurrence of alloxan diabetes in rats.
    Katsumata K; Katsumata Y
    Horm Metab Res; 1990 Mar; 22(3):192-3. PubMed ID: 2344995
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of fasting upon the potentiating effect of tolbutamide on the occurrence of alloxan diabetes.
    Katsumata K; Katsumata Y; Nakagawa T
    Horm Metab Res; 1986 Mar; 18(3):209-10. PubMed ID: 3516836
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of D-400, a herbal formulation, on blood sugar of normal and alloxan-induced diabetic rats.
    Anturlikar SD; Gopumadhavan S; Chauhan BL; Mitra SK
    Indian J Physiol Pharmacol; 1995 Apr; 39(2):95-100. PubMed ID: 7649614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin potentiating effect on development of alloxan diabetes and its prevention by the Ca-channel blocker nicardipine.
    Katsumata K; Miyao M; Katsumata Y
    Horm Metab Res; 1998 Sep; 30(9):557-8. PubMed ID: 9808323
    [No Abstract]   [Full Text] [Related]  

  • 9. Possible antidiabetic and antihyperlipidaemic effect of fermented Parkia biglobosa (JACQ) extract in alloxan-induced diabetic rats.
    Odetola AA; Akinloye O; Egunjobi C; Adekunle WA; Ayoola AO
    Clin Exp Pharmacol Physiol; 2006 Sep; 33(9):808-12. PubMed ID: 16922811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of new hypothalamic peptide on the degree of glycemia in alloxan diabetes].
    Khumarian NG; Khanazadian AKh; Baev VV; Galoian AA
    Zh Eksp Klin Med; 1978; 18(5):15-9. PubMed ID: 751349
    [No Abstract]   [Full Text] [Related]  

  • 11. Production and study of experimental diabetes in mice with alloxan.
    Bhaveja UK; Aurora AL; Agarwal DS
    Indian J Pathol Microbiol; 1982 Jan; 25(1):1-5. PubMed ID: 7106904
    [No Abstract]   [Full Text] [Related]  

  • 12. Coadministration of alloxan and nicotinamide in rats produces biochemical changes in blood and pathological alterations comparable to the changes in type II diabetes mellitus.
    Vattam KK; Raghavendran H; Murali MR; Savatey H; Kamarul T
    Hum Exp Toxicol; 2016 Aug; 35(8):893-901. PubMed ID: 26429928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidiabetic effects of S-methylcysteine sulphoxide on alloxan diabetes.
    Kumari K; Augusti KT
    Planta Med; 1995 Feb; 61(1):72-4. PubMed ID: 7700997
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypoglycemic effect of trans-dehydrocrotonin, a nor-clerodane diterpene from Croton cajucara.
    Farias RA; Rao VS; Viana GS; Silveira ER; Maciel MA; Pinto AC
    Planta Med; 1997 Dec; 63(6):558-60. PubMed ID: 9434613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Protective effect of indomethacin on alloxan-induced diabetes in rat].
    Xu WX; Yu JR
    Sheng Li Xue Bao; 1992 Apr; 44(2):202-8. PubMed ID: 1621111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Verapamil induces protection of alloxan but not streptozotocin-induced diabetes in rats.
    Katsumata K; Miyao K; Katsumata Y
    Horm Metab Res; 1988 Jan; 20(1):65. PubMed ID: 2967238
    [No Abstract]   [Full Text] [Related]  

  • 17. [Animal sensitivity to the diabetogenic action of alloxan during cold adaptation].
    Shorin IuP; Seliatitskaia VG; Nepomniashchikh GI; Pal'chikova NA; Khodova RR
    Biull Eksp Biol Med; 1984 Aug; 98(8):240-2. PubMed ID: 6466864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of dopaminergic pharmacological agents on the pancreatic islet apparatus in rats].
    Boiadzhieva N
    Eksp Med Morfol; 1990; 29(3):20-6. PubMed ID: 1980459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Ballota nigra on glucose and insulin in alloxan-diabetic albino rats.
    Nusier MK; Bataineh HN; Bataineh ZM; Daradka HM
    Neuro Endocrinol Lett; 2007 Aug; 28(4):470-2. PubMed ID: 17627273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-arginine and polyamine administration protect beta-cells against alloxan diabetogenic effect in Sprague-Dawley rats.
    Méndez JD; Hernández Rde H
    Biomed Pharmacother; 2005 Jul; 59(6):283-9. PubMed ID: 15996850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.